ストックスクリーナーアプリを入手
7.86
1.95%
0.15
プレマーケット:
7.52
-0.34
-4.33%
前日終値:
$7.71
開ける：
$7.87
24時間の取引高:
764.77K
Relative Volume:
0.93
時価総額：
$770.92M
収益：
-
当期純損益:
$-209.96M
株価収益率:
-2.4873
EPS:
-3.16
ネットキャッシュフロー:
$-176.27M
1週間 パフォーマンス:
-21.48%
1か月 パフォーマンス:
+6.94%
6か月 パフォーマンス:
-35.52%
1年 パフォーマンス:
+22.62%
1日の値動き範囲:
$7.67
$8.28
1週間の範囲:
$6.93
$9.96
52週間の値動き範囲:
$4.92
$17.00
Replimune Group Inc Stock (REPL) Company Profile
REPL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
REPL
Replimune Group Inc
|
7.86 | 770.92M | 0 | -209.96M | -176.27M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Replimune Group Inc Stock (REPL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-28 | 開始されました | ROTH MKM | Buy |
| 2023-04-17 | 再開されました | Piper Sandler | Overweight |
| 2021-11-19 | 開始されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2020-11-17 | 開始されました | BTIG Research | Buy |
| 2020-11-02 | 開始されました | Jefferies | Buy |
| 2020-10-15 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-07-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-05-05 | 開始されました | Barclays | Overweight |
| 2019-09-04 | 開始されました | ROTH Capital | Buy |
| 2019-07-23 | 開始されました | Chardan Capital Markets | Buy |
| 2019-07-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-07-08 | 開始されました | H.C. Wainwright | Buy |
| 2019-04-25 | 開始されました | Wedbush | Outperform |
| 2019-01-23 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-08-14 | 開始されました | JP Morgan | Overweight |
| 2018-08-14 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Replimune Group Inc (REPL) 最新ニュース
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Dimensional Fund Advisors LP - Defense World
Stifel Financial Corp Purchases 13,916 Shares of Garrett Motion Inc. (NYSE:GTX) - Defense World
Tower Research Capital LLC TRC Acquires 5,922 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Tower Research Capital LLC TRC Has $81,000 Holdings in Ingles Markets, Incorporated (NASDAQ:IMKTA) - Defense World
Lightwave Logic, Inc. (NASDAQ:LWLG) Holdings Increased by Wells Fargo & Company MN - Defense World
Tencent Music Entertainment Group (TME) to Release Earnings on Tuesday - Defense World
Premium Brands (TSE:PBH) Stock Price Expected to Rise, Desjardins Analyst Says - Defense World
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | REPL Stock News - GuruFocus
MP Materials (NYSE:MP) Stock Price Down 8.2% on Disappointing Earnings - Defense World
Keep Talking: US FDA’s Beleaguered Biologics Center Remains Vital To Regenerative Medicine - insights.citeline.com
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Roth Capital Issues Negative Forecast for Upwork Earnings - Defense World
Brokerages Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $19.43 - Defense World
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for EverQuote (NASDAQ:EVER) Stock - Defense World
Replimune Group (REPL) Projected to Post Earnings on Thursday - Defense World
Alibaba Group (BABA) Projected to Post Quarterly Earnings on Thursday - Defense World
Tanger Inc. (NYSE:SKT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Pason Systems (OTCMKTS:PSYTF) Stock Price Down 0.6% – Should You Sell? - Defense World
Tower Research Capital LLC TRC Has $147,000 Position in Edgewell Personal Care Co (NYSE:EPC) - Defense World
MetLife Investment Management LLC Raises Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Mariner LLC Purchases Shares of 3,038 Brady Co. (NYSE:BRC) - Defense World
(REPL) On The My Stocks Page - news.stocktradersdaily.com
Shore Capital Reiterates Buy Rating for Keystone Law Group (LON:KEYS) - Defense World
Invesco Ltd. Sells 92,952 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Perhaps timely catching Replimune Group Inc (REPL) would be a good idea - Sete News
A stock that deserves closer examination: Replimune Group Inc (REPL) - uspostnews.com
XTX Topco Ltd Purchases New Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Wells Fargo & Company MN - Defense World
Potential Price Increase for Replimune Group Inc (REPL) After Recent Insider Activity - knoxdaily.com
Market Insights: Replimune Group Inc (REPL)’s Notable Gain of 2.43, Closing at 9.27 - DWinneX
Legal & General Group Plc Has $719,000 Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune: Scope Goes Beyond That Of RP1 Oncolytic Targeting For Melanoma (NASDAQ:REPL) - Seeking Alpha
Are Replimune Group Inc’shares a good deal? - uspostnews.com
Market Momentum Report: Replimune Group Inc (REPL)’s Positive Close at 8.83 - DWinneX
The Growing Financial Burden on Patients and Caregivers in Cancer Care - Targeted Oncology
A Detailed Analysis Of Replimune Group Inc (REPL) - Marketing Sentinel
Could The Upcoming FDA Decision Ignite Investor Confidence In REPL? - RTTNews
Replimune Group Inc (REPL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Benzinga
First-Line CLL/SLL: Is Chemo-Free the Future? - Targeted Oncology
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Has $5.89 Million Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Alliancebernstein L.P. Sells 48,397 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Vanguard Group Inc. Has $43.55 Million Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA - MSN
Sei Investments Co. Purchases New Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune stock target raised to $22 at H.C. Wainwright - MSN
Navigating Uncertainty: Replimune Group’s Strategic Challenges Amid Clinical Trials and Global Risks - MSN
Is Replimune Group (NASDAQ:REPL) A Risky Investment? - simplywall.st
Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Rating of “Buy” from Analysts - Defense World
KLP Kapitalforvaltning AS Takes Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group Inc (REPL) 財務データ
収益
当期純利益
現金流量
EPS
4.10%
大文字化:
|
ボリューム (24 時間):